Literature DB >> 17964909

Insulin resistance as the underlying cause for the metabolic syndrome.

Danielle Lann1, Derek LeRoith.   

Abstract

Classically, the metabolic syndrome is characterized as group of pathologies including visceral obesity, hypertension, dyslipidemia, and impaired glucose tolerance. It is now realized that insulin resistance plays a principal role in initiating and perpetuating the pathologic manifestations of the metabolic syndrome. A more in-depth understanding of the basic pathophysiologic mechanisms underlying insulin resistance may aid clinicians in treating and possibly delaying or even preventing the onset of the metabolic syndrome and its complications. This article outlines how abnormal insulin signaling and secretion, impaired glucose disposal, lipotoxicity, and proinflammatory cytokines exacerbate insulin resistance and result in the perturbations of the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964909     DOI: 10.1016/j.mcna.2007.06.012

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  54 in total

Review 1.  The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

Authors:  Menno Vergeer; Adriaan G Holleboom; John J P Kastelein; Jan Albert Kuivenhoven
Journal:  J Lipid Res       Date:  2010-04-06       Impact factor: 5.922

2.  Association of metabolic syndrome with reduced central serotonergic activity.

Authors:  Rocio Herrera-Marquez; Jorge Hernandez-Rodriguez; Julio Medina-Serrano; Alfonso Boyzo-Montes de Oca; Gabriel Manjarrez-Gutierrez
Journal:  Metab Brain Dis       Date:  2010-12-22       Impact factor: 3.584

3.  Essentials of healthy eating: a guide.

Authors:  Patrick J Skerrett; Walter C Willett
Journal:  J Midwifery Womens Health       Date:  2010 Nov-Dec       Impact factor: 2.388

4.  A novel, rapid, inhibitory effect of insulin on alpha1beta2gamma2s gamma-aminobutyric acid type A receptors.

Authors:  Daniel B Williams
Journal:  Neurosci Lett       Date:  2008-07-19       Impact factor: 3.046

5.  Bivariate genetic modelling of the response to an oral glucose tolerance challenge: a gene x environment interaction approach.

Authors:  G F Liu; H Riese; T D Spector; M Mangino; S D O'Dell; R P Stolk; H Snieder
Journal:  Diabetologia       Date:  2009-03-14       Impact factor: 10.122

Review 6.  Saponin as regulator of biofuel: implication for ethnobotanical management of diabetes.

Authors:  Olusola Olalekan Elekofehinti; Idowu Olaposi Omotuyi; Jean Paul Kamdem; Oluwamodupe Cecilia Ejelonu; Guimarae Vanessa Alves; Isaac Gbadura Adanlawo; João Batista Teixeira Rocha
Journal:  J Physiol Biochem       Date:  2014-02-25       Impact factor: 4.158

7.  The 60- and 70-kDa heat-shock proteins and their correlation with cardiovascular risk factors in postmenopausal women with metabolic syndrome.

Authors:  Eliana A P Nahas; Jorge Nahas-Neto; Claudio L Orsatti; Ana Paula Tardivo; Gilberto Uemura; Maria Terezinha S Peraçoli; Steven S Witkin
Journal:  Cell Stress Chaperones       Date:  2013-12-11       Impact factor: 3.667

8.  A high protein moderate carbohydrate diet fed at discrete meals reduces early progression of N-methyl-N-nitrosourea-induced breast tumorigenesis in rats.

Authors:  Christopher J Moulton; Rudy J Valentine; Donald K Layman; Suzanne Devkota; Keith W Singletary; Matthew A Wallig; Sharon M Donovan
Journal:  Nutr Metab (Lond)       Date:  2010-01-10       Impact factor: 4.169

9.  Lipoprotein lipase expression, serum lipid and tissue lipid deposition in orally-administered glycyrrhizic acid-treated rats.

Authors:  Wai Yen Alfred Lim; Yoke Yin Chia; Shih Yeen Liong; So Ha Ton; Khalid Abdul Kadir; Sharifah Noor Akmal Syed Husain
Journal:  Lipids Health Dis       Date:  2009-07-29       Impact factor: 3.876

10.  Inverse association between insulin resistance and gait speed in nondiabetic older men: results from the U.S. National Health and Nutrition Examination Survey (NHANES) 1999-2002.

Authors:  Chen-Ko Kuo; Lian-Yu Lin; Yau-Hua Yu; Kuan-Han Wu; Hsu-Ko Kuo
Journal:  BMC Geriatr       Date:  2009-11-19       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.